- Report
- January 2024
- 175 Pages
Global
From €4808EUR$5,000USD£4,124GBP
- Report
- January 2024
- 200 Pages
Global
From €4808EUR$5,000USD£4,124GBP
- Report
- February 2024
- 185 Pages
Global
From €4712EUR$4,900USD£4,042GBP
- Report
- April 2023
- 120 Pages
Global
From €4567EUR$4,750USD£3,918GBP
- Report
- August 2020
- 113 Pages
Global
From €4087EUR$4,250USD£3,506GBP
- Report
- June 2021
- 50 Pages
China
From €2500EUR$2,600USD£2,145GBP
- Drug Pipelines
- September 2020
- 57 Pages
Global
From €1923EUR$2,000USD£1,650GBP
- Report
- October 2023
- 83 Pages
Global
From €3500EUR$3,899USD£3,108GBP
- Report
- January 2021
- 144 Pages
China, Global
From €3000EUR$3,342USD£2,664GBP
- Report
- February 2024
- 106 Pages
Global
From €3500EUR$3,899USD£3,108GBP
- Drug Pipelines
- June 2020
- 65 Pages
Global
From €1923EUR$2,000USD£1,650GBP
- Report
- May 2024
- 50 Pages
Global
From €2548EUR$2,650USD£2,186GBP
Pantoprazole is a proton pump inhibitor (PPI) used to treat gastrointestinal disorders such as gastroesophageal reflux disease (GERD), erosive esophagitis, and Zollinger-Ellison syndrome. It is also used to reduce the risk of stomach ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs). Pantoprazole works by decreasing the amount of acid produced in the stomach.
Pantoprazole is available in both prescription and over-the-counter forms. It is available as a tablet, capsule, and powder for suspension. It is also available in combination with other medications, such as amoxicillin and clarithromycin, for the treatment of Helicobacter pylori infection.
The Pantoprazole market is a part of the larger Gastrointestinal Drugs market. This market includes a variety of drugs used to treat gastrointestinal disorders, such as antacids, proton pump inhibitors, H2 receptor antagonists, and prokinetics. These drugs are used to treat a wide range of gastrointestinal disorders, including GERD, peptic ulcer disease, irritable bowel syndrome, and inflammatory bowel disease.
Some companies in the Pantoprazole market include AstraZeneca, Pfizer, Takeda Pharmaceuticals, and Sun Pharmaceuticals. Show Less Read more